The value proposition of Contract Development and Manufacturing Organizations (CDMOs) has become increasingly crucial in the pharmaceutical industry. As the […]
Source
In the high-stakes world of biosimilar development, manufacturers are increasingly turning to an unexpected partner: the Patent Trial and Appeal […]
Source
Biosimilar Patent Dance: Leveraging PTAB Challenges for Strategic Advantage Read Post »
This is an example from the DrugPatentWatch AI Research Assistant, which is available with DrugPatentWatch subscriptions. The DrugPatentWatch AI Research […]
Source
Viagra’s Resilience in the Face of Generic Competition: A Pharmaceutical Market Analysis Read Post »
The introduction of biosimilars has significantly altered the landscape of biologic drug distribution models. Biosimilars, which are highly similar to […]
Source
The impact of biosimilars on biologic drug distribution models Read Post »
In a seismic shift for European intellectual property, the Unified Patent Court (UPC) is rapidly transforming how businesses approach patent […]
Source
Unified Patent Court Reshapes European Patent Landscape Read Post »
To find low-competition generic drug opportunities, focus on drugs with limited competition due to small patient populations, complex formulations, or […]
Source
How to find low-competition generic drug opportunities Read Post »
The integration of artificial intelligence (AI) into drug discovery and development is revolutionizing the pharmaceutical industry. AI’s ability to analyze […]
Source
Patenting Drugs Developed with Artificial Intelligence: Navigating the Legal Landscape Read Post »
China is emerging as a global frontrunner in patenting artificial intelligence (AI) technologies for drug discovery, particularly in the field […]
Source
The pharmaceutical industry is a high-stakes arena where innovation, investment, and intellectual property (IP) protection intersect. One of the most […]
Source
The Power of Patience: Delaying Patents to Enhance Pharma Market Exclusivity Read Post »
Lipitor’s marketing strategy underwent a significant evolution as generic competition emerged, employing aggressive tactics to retain market share and brand […]
Source
How can pharmaceutical marketing evolve with generic entry? The example of Lipitor Read Post »